Companies / Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd.

NYSE: CANFForeign · IFRSCIK 1536196RAMAT GAN

Financials · FY2025

Revenue$405.0K
Net income$-9.83M
Total debt—
Cash$5.53M
Diluted EPS$-5.97
Shares outstanding2.6M

Ownership

2.6M shares outstanding
0.80%Institutions
Ownership
Institutions0.80%20,909
Public float99.20%2,597,516

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Bornstein YosephDirector
——
Farbstein MottiCEOCEO, CFO and COO
——
Fishman PninaChief Scientific Officer · Director
——
Fishman SariVP Business Development
——
Sartani AbrahamDirector
——

Institutional holders 2

View all →
HolderValue% of shares
Rhumbline Advisers$64.8K0.80%
SBI Securities Co., Ltd.$0<0.01%

Activity

Mar 31, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Rhumbline Advisers
13F manager
NewADR$64.8K+21K
20,908
0.80% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CANFADREquity13471N409BBG003CMFDM2